Temsirolimus
Catalog #
27024
$125
*
●
●
Purchase
Description
Temsirolimus, a rapamycin (sirolimus) derivative, also known as CCI-779, is an mTOR inhibitor with anti-cancer activity. Temsirolimus down-regulated the mTOR signaling intermediate phospho-S6 in xenografted human ALL. Temsirolimus has been shown to reverse cisplatin resistance in small cell lung cancer cell lines selected for cisplatin resistance and in cell lines derived from patients who failed cisplatin therapy.
●
Synonyms
CCI-779, Torisel
Product Info
Storage and Usage
Citations
Purity
≥99%
Format
White to off-white solid.
Formula
C56H87NO16
MW
1030.3 Da
Solubility
Soluble in DMSO at 200 mg/ml; soluble in ethanol at 200 mg/ml; very poorly soluble in water; maximum solubility in plain water is estimated to be about 10-20 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility.
CAS Registry #
162635-04-3
References
1. Wan, X., et al. Neoplasia 8: 394-401 (2006).
2. Teachey, D.T., et al. Blood 107: 1149-1155 (2006).
3. Wu, C., et al. Mol. Cancer 4: 25-34 (2005).
2. Teachey, D.T., et al. Blood 107: 1149-1155 (2006).
3. Wu, C., et al. Mol. Cancer 4: 25-34 (2005).